Core Viewpoint - The article discusses the launch of an AI family doctor product by YaoYing Medical, which utilizes large language model technology to provide 24/7 intelligent dialogue, multi-turn interactions, and personalized health advice, covering areas such as smart consultations, health assessments, medication inquiries, and test report interpretations [1][2]. Group 1: Company Overview - YaoYing Medical was established in 2016 and has developed a service model that combines general and specialized care, with a team of hundreds of medical professionals and a network of 9 clinics and 1 hospital in the Yangtze River Delta region [1]. - The company has served over 1 million patients in its 9 years of operation, with more than 50% of its clientele coming from commercial insurance channels [2]. Group 2: AI Family Doctor Product - The AI family doctor aims to address the challenges of accessibility, resource distribution, and trust in traditional family doctor setups, which often lack 24/7 availability and personalized patient understanding [2][4]. - The product is designed to ensure reliability by combining AI capabilities with human medical expertise, where AI provides preliminary assessments while final decisions rest with qualified doctors [5][8]. Group 3: Technological Integration - YaoYing Medical collaborates with the Shanghai Artificial Intelligence Laboratory to enhance the AI family doctor's capabilities, focusing on reducing AI hallucination rates through intent recognition and relevant information integration [5][8]. - The company has built a structured database that includes patient history, imaging tests, laboratory results, and data from wearable devices, which supports the AI in delivering personalized services [8]. Group 4: Operational Efficiency - The AI family doctor can handle routine inquiries and organize patient history, allowing doctors to focus on complex case diagnoses and treatment planning, significantly reducing the time required for documentation [11]. - The AI system is expected to alleviate the burden on community doctors, enabling them to manage a larger patient base effectively [11]. Group 5: Future Directions - YaoYing Medical plans to expand its services from general to specialized medical fields, creating a seamless intelligent medical ecosystem [12]. - The company envisions the ultimate form of AI in healthcare as "Digital Therapeutics," which will not only provide health advice but also generate and monitor personalized treatment plans [12].

Core Viewpoint - The article discusses the launch of an AI family doctor product by YaoYing Medical, which utilizes large language model technology to provide 24/7 intelligent dialogue, multi-turn interactions, and personalized health advice, covering areas such as smart consultations, health assessments, medication inquiries, and test report interpretations [1][2]. Summary by Sections Company Overview - YaoYing Medical was established in 2016 and has developed a service model that combines general and specialized care, with a team of hundreds and a network of 9 clinics and 1 hospital in the Yangtze River Delta region, serving over one million patients [1][6]. AI Family Doctor Product - The AI family doctor product aims to address the pain points of family health management, providing a trustworthy and efficient healthcare experience by integrating AI technology with professional medical judgment [1][2]. - The product is designed to ensure reliability by combining AI capabilities with human doctors, where AI provides preliminary assessments while final decisions rest with medical professionals [8][11]. Challenges and Solutions - Key challenges in developing the AI family doctor include ensuring the AI possesses professional medical knowledge and can manage multiple patient data effectively [4]. - To combat AI hallucinations, YaoYing Medical collaborates with the Shanghai Artificial Intelligence Laboratory, employing techniques such as intent recognition and integrating relevant patient information to enhance reliability [5][8]. Service Model - The dual-track service model of "AI + human doctors" is emphasized, where AI offers initial guidance and human doctors oversee the final decision-making process, ensuring a seamless connection between online and offline medical services [8][11]. - The AI family doctor can handle routine inquiries and organize medical histories, allowing doctors to focus on more complex cases, thus improving overall efficiency [11]. Future Directions - YaoYing Medical plans to expand its services from general to specialized fields, aiming to create a seamless smart medical ecosystem [12]. - The company envisions the ultimate form of AI in healthcare as "Digital Therapeutics," which will go beyond providing health advice to generating personalized treatment plans [12].

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [12]. - Participants must fill out a specific form or send an email with required details to apply for the awards [13]. Group 4: Evaluation Criteria - The awards are aimed at various entities including medical device companies, healthcare institutions, and service providers, with criteria focusing on originality, advanced technology, clinical application, and industry impact [7][10][11]. - Specific standards are set for each award category, emphasizing the need for innovative products or technologies that demonstrate clear clinical efficacy and potential for widespread application [10][11]. Group 5: Conference Agenda - The conference will cover topics such as global medical technology development trends, research and transformation paths for imaging platforms, new consumables, brain-machine interfaces, interventional devices, diagnostic equipment, and the integration of AI in healthcare [6]. - It will also address capital market interests in technology directions and enterprise profiles, as well as overseas market access and marketing strategies [6].

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, 2025, with results to be announced between June 30 and July 4, 2025 [11]. - The awards will be presented on July 17, 2025, after the confirmation of trophy production [11]. Group 4: Target Audience and Standards - The awards target various entities including medical device and digital health technology companies, clinical doctors, researchers, and key suppliers, with specific standards for originality, advancement, and potential for industrialization [7][10].

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [11]. - Participants must meet specific criteria based on their roles, such as medical device companies, clinical doctors, researchers, and service providers, ensuring that the innovations are original, advanced, and have potential for large-scale industrialization [7][10].

Core Viewpoint - The article announces the extension of the application deadline for the Global MedTech Innovation Awards to June 20, 2025, to allow more time for participants to prepare their submissions and showcase their innovations in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference aims to highlight and award groundbreaking achievements in medical technology, with a focus on innovation, application, and service contributions [4][8]. Group 2: Award Categories - The awards include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4 [11]. - Participants must submit specific documents including a personal resume, a summary of research achievements, and any relevant supporting materials [13].

Core Viewpoint - The medical technology industry is at a crossroads of breakthrough and reconstruction, with advancements in AI-assisted diagnosis, high-end intelligent diagnostic equipment, innovative medical materials, and regenerative medicine reshaping disease discovery, treatment, and management [1] Group 1: Conference Overview - The Second Global MedTech Conference will be held on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, aiming to promote the collaborative development of the global medical technology industry chain, innovation chain, and clinical application [1][4] - The first conference, Global MedTech Conference 2024, was organized by Siyu [2] Group 2: Awards and Recognition - The conference will present several awards to recognize breakthroughs in medical technology, including the 2025 Global MedTech Innovation Award and the 2025 Global MedTech Innovation Application Award [3][7] - The awards aim to honor cutting-edge technological advancements, successful results transformation, and outstanding services in the medical technology field [3] Group 3: Conference Agenda - Proposed agenda topics include analysis of global medical technology development trends and policy environments, research and transformation paths for imaging platforms, new consumables, brain-computer interfaces, interventional devices, and diagnostic equipment [5] - Other topics will cover experiences in the intersection of medicine and engineering, breakthroughs in AI-assisted diagnosis and digital therapy, and insights into technology directions and company profiles attracting domestic and foreign capital [5] Group 4: Participation and Submission Guidelines - The awards are open to medical device and digital medical technology companies with innovative products or platform technologies that demonstrate originality, advancement, and potential for large-scale industrialization [6] - Submission for the awards is open until May 31, 2025, with a review phase from June 1 to June 15, 2025, and results to be announced between June 16 and June 22, 2025 [10]

2025年3月25日，海易特医疗科技(上海)有限公司与上海交通大学医学院附属上海儿童医学中心在 儿童医学中心的张江院区共同举办了"儿童肿瘤康复机器人系统联合开发项目"启动会。此次项目标志着 双方在儿童肿瘤康复领域的技术创新与临床应用的深度合作正式启航。 启动会现场，上海儿童医学中心张江院区的小儿外科肿瘤外科主任顾松率先发表致辞。他首先对来 到启动会的各位嘉宾表示热烈欢迎，随后他对医学中心进行了简单介绍，他提到上海儿童医学中心是三 个国家儿童医学中心之一，张江院区在治疗儿童肿瘤方面无论在规模上，还是技术上都是顶尖的，针对 院内儿童恶性肿瘤彻底治愈率有着非常高的水平。本次也由衷地希望与海易特公司合作研发康复机器人 系统来解决儿童肿瘤患者肌无力、肌少症等康复问题。临床研究中心的王友俊主任提到：儿童医学中心 在小儿的治疗、康复、心理辅导方面有着全周期的管理模式，他对海易特技术的专业性及康复行业的热 情表示非常认可，并希望通过双方共同的努力，未来将儿童医学中心建造成更有温度的医院。 随后，海易特医疗科技的董事长范卫东也进行了发言，他表示公司会尽最大努力将技术及专家力量 投入到设备的研发中，加快推进康复机器人系统的落地， ...

北极光创投创始管理合伙人邓锋（右二）在上市仪式现场。 本文为IPO早知道原创 作者｜Stone Jin 微信公众号｜ipozaozhidao 据IPO早知道消息，脑动极光医疗科技有限公司（以下简称"脑动极光"）于2025年1月8日正式 以"6681"为股票代码在港交所主板挂牌上市，成为"中国数字疗法第一股"。 截至10:00，脑动极光报于每股3.48港元，较发行价上涨8.07%，市值超44亿港元。 成立于2 012 年的 脑动极光 作为 中国认知障碍数字疗法市场的资深参与者，也是中国首家将脑科 学与先进的人工智能技术相结合开发医疗级数字疗法产品的公司，产品管线涵盖由血管疾病、神经退 行性疾病、精神疾病及儿童发育缺陷等诱发的广泛的认知障碍的测评和干预。 截至2024年12月21日，脑动极光的核心产品「脑功能信息管理平台软件系统」已就四种主要类型认 知障碍的八种适应症实现商业化，且正在开发其他几种认知障碍适应症。截至同日，脑动极光有另外 三款产品已于中国获得监管批准（基本认知能力测验软件（BCAT）、认知能力辅助筛查评估软件 （SAS）及阅读障碍辅助筛查评估软件（DSS））、另有一款产品已于欧盟获得监管批准（认知 ...